What’s your Poison?

by Craig Paardekooper

It seems obvious, but the toxicity of a poison can be determined by its lethality – the % of people who die
after taking it.
In the same way, the toxicity of a lot might be measured by the % of adverse reaction reports resulting in a fatality
for that lot.

Some lots appear to be more toxic than others
When I examined the Pfizer lots, I found that they grouped into alphabetic series such as EN, ER, EW, FA, FC, FF.
Within each of these alphabetic groups I observed the following 1. there was a distinct group of lots displaying very high numbers of adverse reactions – typically 100 times
greater than any of the remaining lots in that same alphabetic group.
2. there was no gradual transition from lots with high adverse reactions to lots with low adverse reactions –instead there was a sudden drop by 2 orders of magnitude.
3. the lots with very high adverse reaction numbers had batch codes belonging to the same sequential
mathematical series.
Between each of these alphabetic groups I observed the following 4. there was a linear stepwise decrease in adverse reactions as the group ascended the alphabet.
This gave every appearance that the lots were varying in toxicity, not just within their own alphabetic group, but
between groups also, and that this variation in toxicity had been carefully labelled with sequential mathematicalbatch codes.

Measuring the lethality
First, I identified the lots with high adverse reaction numbers in each alphabetic group. (see p 3, 4, 5) .
[Data was from VAERS 2021 for USA only. I will need to repeat this study for VAERS 2021 Outside of USA.]
Then I counted the number of deaths for these lots, and divided that by the total number of adverse reports forthese lots.
% Lethality = Number of Deaths/Total number of Reports * 100
This gave me the % of the reports resulting in death.

Results% Lethality
EK Series

7047 adverse reports

99 deaths

lethality = 1.4%

EL Series

31140 adverse reports

913 deaths

lethality = 2.9%

EN Series

30354 adverse reports

780 deaths

lethality = 2.5%

ER Series

24288 adverse reports

243 deaths

lethality = 1%

EW Series

49233 adverse reports

311 deaths

lethality = 0.6%

% Disability
EK Series7047 adverse reports

103 disableddisability = 1.4%

EL Series

31140 adverse reports

585 disableddisability = 1.8%

EN Series

30354 adverse reports

699 disableddisability = 2.3%

ER Series

24288 adverse reports

522 Disableddisability = 2.1%

EW Series

49233 adverse reports

858 disableddisability = 1.7%

Conclusion
So the stepwise decline in adverse reactions coincides with a stepwise reduction in the % of reports resulting indeath – indicating that the lots with high adverse reaction numbers really are more toxic.
It is also observed that as the % of reports resulting in death decreases, the % of reports resulting in disability rises. If
death is considered to be a terminal level of disability, then reducing toxicity would cause the same people toexperience non-terminal disabilities instead – a kind of living death.

This chart shows the lots arranged by batch code alphabetically along the x axis. The y axis shows the number ofadverse reactions for each lot.
You can see how lots form groups with very similar batch codes, where the codes are all part of the samemathematical series. You can also see how these series identify distinct ranges of toxicity.

Here is a close up of the EK Series.
I calculated the % lethality for the lots shaded in yellow.
1.4% of adverse reaction reports ended in fatality.

Here is a close up of the EL Series.
I calculated the % lethality for the lots shaded in yellow.
2.9% of adverse reaction reports ended in fatality.

Here is a close up of the EN Series.
I calculated the % lethality for the lots shaded in yellow.
2.5% of adverse reaction reports ended in fatality.

Here is a close up of the ER Series
I calculated the % lethality for the lots shaded in yellow.
1% of adverse reaction reports ended in fatality.

Here is a close up of the EW Series
I calculated the % lethality for the lots shaded in yellow.
0.6% of adverse reaction reports ended in fatality.